Tanke Biosciences Corp (TNBI) stock
TNBIOTCGrain Mill ProductsFiscal year ends December 31
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $399.72KP/E –Yield –
Earnings
Tanke Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Tanke Biosciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2011ended Jun 30, 2011 | Aug 15, 2011during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Tanke Biosciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Tanke Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.
See a number that looks wrong?